| Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial JC Tardif, N Bouabdallaoui, PL L'allier, D Gaudet, B Shah, MH Pillinger, ... The Lancet Respiratory Medicine 9 (8), 924-932, 2021 | 299 | 2021 |
| Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) N Bouabdallaoui, JC Tardif, DD Waters, FJ Pinto, AP Maggioni, R Diaz, ... European heart journal 41 (42), 4092-4099, 2020 | 248 | 2020 |
| Alterations in portal vein flow and intrarenal venous flow are associated with acute kidney injury after cardiac surgery: a prospective observational cohort study W Beaubien‐Souligny, A Benkreira, P Robillard, N Bouabdallaoui, ... Journal of the American Heart Association 7 (19), e009961, 2018 | 206 | 2018 |
| Efficacy of colchicine in non-hospitalized patients with COVID-19 JC Tardif, N Bouabdallaoui, PL L’Allier, D Gaudet, B Shah, MH Pillinger, ... Medrxiv, 2021.01. 26.21250494, 2021 | 121 | 2021 |
| Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging F Mouquet, C Lions, P de Groote, N Bouabdallaoui, S Willoteaux, ... European radiology 18, 2765-2769, 2008 | 105 | 2008 |
| Vascular and microvascular endothelial function in heart failure with preserved ejection fraction S Maréchaux, R Samson, E Van Belle, J Breyne, J De Monte, C Dédrie, ... Journal of cardiac failure 22 (1), 3-11, 2016 | 96 | 2016 |
| Colchicine for secondary prevention of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials M Samuel, JC Tardif, N Bouabdallaoui, P Khairy, MP Dubé, L Blondeau, ... Canadian Journal of Cardiology 37 (5), 776-785, 2021 | 88 | 2021 |
| Care gaps in adherence to heart failure guidelines: clinical inertia or physiological limitations? M Jarjour, C Henri, S de Denus, A Fortier, N Bouabdallaoui, A Nigam, ... Heart Failure 8 (9), 725-738, 2020 | 88 | 2020 |
| Growth differentiation factor‐15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the … N Bouabdallaoui, B Claggett, MR Zile, JJV McMurray, E O'Meara, ... European journal of heart failure 20 (12), 1701-1709, 2018 | 80 | 2018 |
| Aortic regurgitation in patients with a left ventricular assist device: a contemporary review N Bouabdallaoui, I El-Hamamsy, M Pham, G Giraldeau, MC Parent, ... The Journal of Heart and Lung Transplantation 37 (11), 1289-1297, 2018 | 76 | 2018 |
| Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) M Samuel, JC Tardif, P Khairy, F Roubille, DD Waters, JC Grégoire, ... European Heart Journal-Quality of Care and Clinical Outcomes 7 (5), 486-495, 2021 | 58 | 2021 |
| Functional mitral regurgitation: a link to pulmonary hypertension in heart failure with preserved ejection fraction S Maréchaux, DV Neicu, S Braun, M Richardson, P Delsart, ... Journal of cardiac failure 17 (10), 806-812, 2011 | 53 | 2011 |
| Portal hypertension is associated with congestive encephalopathy and delirium after cardiac surgery A Benkreira, W Beaubien-Souligny, T Mailhot, N Bouabdallaoui, ... Canadian Journal of Cardiology 35 (9), 1134-1141, 2019 | 52 | 2019 |
| Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière C Mastroianni, N Bouabdallaoui, P Leprince, G Lebreton European Heart Journal: Acute Cardiovascular Care 6 (1), 87-92, 2017 | 45 | 2017 |
| Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction S Maréchaux, MM Six-Carpentier, N Bouabdallaoui, D Montaigne, ... Heart and vessels 26, 313-320, 2011 | 45 | 2011 |
| Anaemia to predict outcome in patients with acute coronary syndromes PV Ennezat, S Maréchaux, C Pinçon, J Finzi, S Barrailler, ... Archives of cardiovascular diseases 106 (6-7), 357-365, 2013 | 37 | 2013 |
| Society of Thoracic Surgeons risk score and EuroSCORE-2 appropriately assess 30-day postoperative mortality in the STICH trial and a contemporary cohort of patients with left … N Bouabdallaoui, SR Stevens, T Doenst, MC Petrie, N Al-Attar, IS Ali, ... Circulation: Heart Failure 11 (11), e005531, 2018 | 35 | 2018 |
| Short-term mechanical circulatory support for cardiogenic shock in severe peripartum cardiomyopathy: La Pitié-Salpêtrière experience N Bouabdallaoui, P Demondion, P Leprince, G Lebreton Interactive CardioVascular and Thoracic Surgery 25 (1), 52-56, 2017 | 32 | 2017 |
| Addition of B-type natriuretic peptide to the GRACE score to predict outcome in acute coronary syndrome: a retrospective (development) and prospective (validation) cohort-based … T Guidez, S Maréchaux, C Pinçon, H Lamour, S Barrailler, V Decourcelle, ... Emergency Medicine Journal 29 (4), 274-279, 2012 | 32 | 2012 |
| Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease N Bouabdallaoui, N Messas, N Greenlaw, R Ferrari, I Ford, KM Fox, ... European journal of preventive cardiology 28 (13), 1460-1466, 2021 | 30 | 2021 |
Philippe PibarotProfessor Medicine, Laval University在 med.ulaval.ca 的电子邮件经过验证
